First Medication for Huntington's Chorea Approved
Tetrabenazine does not slow progression of the disease, which affects most people in middle age. Prestwick Pharmaceutical, Inc., a privately held company in Washington D.C., owns the rights to develop and sell tetrabenazine in the US. The company specializes in medications treating chronic CNS disorders. Tetrabenazine has been used in Europe for thirty years.